Specialized Disclosure Report (sd)
2023年5月31日 - 5:10AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
SPECIALIZED DISCLOSURE REPORT
IRIDEX CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware |
|
000-27598 |
|
77-0210467 |
(State or other jurisdiction of incorporation) |
|
(Commission file number) |
|
(I.R.S. Employer Identification No.) |
1212 Terra Bella Avenue
Mountain View, California 94043
(Address of principal executive offices, including zip code)
(650) 940-4700
(Registrant’s telephone number, including area code)
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
|
☒ Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2022. |
☐ Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended _____. |
Section 1 - Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure and Report
Conflict Minerals Disclosure
This Form SD of Iridex Corporation (“Iridex”) is filed pursuant to Rule 13p-1 promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period January 1, 2022 to December 31, 2022.
A copy of Iridex’s Conflict Minerals Report is provided as Exhibit 1.01 to this Form SD, and is publicly available under the “Governance Documents” heading on the Corporate Governance page of the Company’s website, which can be reached through the following link: https://iridex.gcs-web.com/corporate-governance-highlights.
Item 1.02 Exhibit
As specified in Item 1.01 of this Form SD, the Company is hereby filing its Conflict Minerals Report as Exhibit 1.01 to this report.
Section 2 - Exhibits
Item 2.01 Exhibits
The following exhibit is filed as part of this Report.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
|
|
|
|
|
|
|
IRIDEX CORPORATION |
|
|
|
|
|
By: |
|
/s/David I. Bruce |
|
|
|
David I. Bruce |
|
|
|
President and Chief Executive Officer |
|
|
|
|
Date: May 30, 2023 |
|
|
|
3
IRIDEX (NASDAQ:IRIX)
過去 株価チャート
から 11 2024 まで 12 2024
IRIDEX (NASDAQ:IRIX)
過去 株価チャート
から 12 2023 まで 12 2024